dr. makker on synergy between lenvatinib and pembrolizumab in endometrial cancer
Published 5 years ago • 1.5K plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:32
dr. makker on safety signals with lenvatinib and pembrolizumab in endometrial cancer
-
0:57
dr. makker on combination approaches in endometrial cancer
-
1:03
dr. makker discusses immunogenicity in endometrial cancer
-
0:13
copy of dr. makker on combination approaches in endometrial cancer
-
1:22
dr. zamarin on the role of pembrolizumab in endometrial cancer
-
0:52
dr. zamarin on lenvatinib plus pembrolizumab in endometrial cancer
-
1:41
dr. makker on unmet needs for patients with advanced endometrial cancer
-
0:53
dr. backes on next steps for lenvatinib and weekly paclitaxel in endometrial cancer
-
0:58
dr. oaknin on the garnet study in endometrial cancer
-
1:14
dr. backes on rationale for lenvatinib and weekly paclitaxel in endometrial cancer
-
0:47
dr. levine on immunotherapy in endometrial cancer
-
7:26
standard frontline therapy for endometrial cancer
-
4:02
#esmo19: lenvatinib (len) and pembrolizumab (pembro) in advanced endometrial cancer
-
2:10
dr. dizon on pten mutations in endometrial cancer
-
0:46
modest response rates in endometrial cancers
-
3:24
endometrial cancer health outcomes: pembrolizumab for patients with msi-high endometrial cancer
-
1:06
dr. glaspy on immunotherapy in endometrial cancer
-
1:01
dr. backes on the film trial in endometrial cancer
-
0:45
dr. rao on the histogenesis of endometrial cancer